Are your advanced therapy supply chains ready for this year’s 4G/LTE data management transition?
A leap forward in standardizing the regenerative medicine supply chain
Date: March 22-26, 2023
Location: Indian Wells, CA
Date: April 5-6, 2023
Location: Tours, France
At Cell&Co BioServices, a Cryoport Systems company, new product innovations are not adopted without significant testing. Recently our team dedicated 3 months to the creation and certification of a new type of cryogenic freezer technology.
Cryoport Systems has grown to become a leader in the cell and gene therapy industry since its founding in 1999. Throughout those 20+ years, we've seen how both the growth and transformation of the market has continually created new life-saving therapies for patients in need. This innovation is particularly true of the modern advancements seen in the last few years.
©2023 Cryoport Systems, LLC. All rights reserved.
A Leap Forward in Standardizing the Regenerative Medicine Supply Chain – What the New ISO 21973 Guidance Means for Cell and Gene Therapy Developers
Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC